Double <i>EGFR</i> mutants containing rare <i>EGFR</i> mutant types show reduced <i>in vitro</i> response to gefitinib compared with common activating missense mutations

Issan Yee San Tam, Maria P. Wong|Molecular Cancer Therapeutics|2009

Cited by 79